Weight loss injection regulation solicitors
JMW advises clinics, prescribers, pharmacists and healthcare businesses on the legal and regulatory requirements governing injectable weight loss treatments, including GLP-1 medicines. We support providers setting up or reviewing their services and represent businesses and professionals facing regulatory investigations or enforcement action.
Weight management services can involve overlapping requirements relating to prescribing, medicines supply, advertising, professional standards and healthcare registration. The obligations that apply depend on the treatment provided, the professionals involved and how the service operates.
Our regulatory and professional discipline team provides practical advice on these requirements, helping clients identify legal risks, respond to concerns and protect their businesses and professional registration.
If you are launching a service, reviewing your prescribing arrangements or responding to a regulator, contact our team on 0345 872 6666 or use our online enquiry form.
On this page
What our clients say
How JMW can help
JMW's team of aesthetic regulation solicitors support individuals and businesses that supply injections and other weight loss treatments. Our thorough understanding of the current legal regime regarding weight loss jabs means that we can support online pharmacies, clinics and other facilities to meet their regulatory obligations, avoid prescribing errors, and support their patients' weight loss.
We advise businesses and professionals involved in weight loss injection services on:
- Prescribing frameworks and clinical governance
- Regulatory compliance and risk management
- CQC registration, scope of registration and changes to existing services
- Advertising and marketing restrictions
- MHRA investigations and enforcement action
- Professional disciplinary proceedings
- Supply chain and procurement issues
- Online prescribing and telemedicine structures
- Off-label prescribing and associated legal and professional obligations
- Responding to inspections, information requests and concerns about patient safety
Our advice focuses on the legal and regulatory framework within which clinical decisions are made. We can review business structures, prescribing and supply arrangements, governance documentation and advertising, and advise on responses to regulatory concerns. Where wider legal issues are, we can coordinate advice from relevant JMW teams.
Our approach is practical, strategic and designed to support safe and compliant business operations. JMW has a strong track record of success in advising organisations and medical professionals on regulatory compliance.
As a full-service firm, we can also support aesthetics businesses with wider legal needs including employment advice, commercial contracts, data protection and criminal defence and defence against weight loss injection compensation claims.
Weight loss injection services often overlap with:
- MHRA enforcement
- Pharmacy regulation
- Advertising and consumer protection law
- Clinical governance requirements
- Data protection and patient confidentiality
- Criminal investigations in serious cases
- Commercial disputes between providers and suppliers
We coordinate advice across JMW to ensure a joined-up response and a comprehensive approach to all of your legal needs.
Meet our team
JMW's expert regulatory solicitors advise aesthetics and medical professionals on the rules governing who can prescribe weight loss drugs and the requirements of informed consent. Our support is designed to enable full compliance, protect your business, and defend you in case of medical negligence claims brought against your practice.
Who we help
JMW's experienced regulatory and professional discipline team advises a wide range of clients on matters related to weight loss injections and other weight loss treatments or non-surgical cosmetic procedures. We can support any of the following individuals and businesses with regulatory compliance and defence services, should an investigation or prosecution arise:
- Aesthetic clinics
- Weight management clinics
- Doctors and independent prescribers
- Nurses and pharmacists
- Online providers and prescribing platforms
- Pharmacy businesses
- Healthcare entrepreneurs and investors
- Suppliers and distributors
We can assist before a service launches, when an existing business changes its operating model or when an investigation, complaint or enforcement issue arises.
Amid growing concerns about how prescriptions are being provided and the role of digital prescribers, it is important for all businesses in the weight loss sector to check and monitor their compliance to minimise the risk of regulatory action.
Are weight loss injection treatments regulated?
Yes, injectable medicines currently licensed for weight management in the UK are prescription-only medicines. Their prescribing, supply or advertising are subject to medicines legislation and relevant professional standards, Prescribing, dispensing, supplying and administering medicines are distinct activities and the requirements for each must be considered separately.
The Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines, including their authorisation, manufacture, distribution and advertising. Healthcare professionals must also comply with the standards of their professional regulator, such as the General Medical Council, Nursing and Midwifery Council or General Pharmaceutical Council.
Healthcare services may require separate registration. In England, this can include registration with the Care Quality Commission (CQC). The General Pharmaceutical Council (GPhC) regulates registered pharmacies and pharmacy professionals in Great Britain; different arrangements apply in Northern Ireland. Healthcare service regulation also differs across the UK’s four nations.
In the private sector, weight loss injections are increasingly offered through:
- Aesthetic clinics
- Private weight management services
- Online prescribing platforms
- Pharmacy-led services
- Hybrid telemedicine models
In England, a physical slimming clinic providing advice or treatment includes prescribing medicines for weight reduction by, or under the supervision of, a registered medical practitioner falls within the CQC-regulated activity of services in slimming clinics, subject to applicable exceptions.
Where a medical practitioner treats obesity through an online service, the regulated activity of treatment of disease, disorder or injury applies. Obesity treatment provided by other listed healthcare professionals can also fall within this activity. The need for registration must be assessed against the actual service. Registration of one part of a business does not necessarily cover every activity, location or legal entity involved
Why are weight loss injections under regulatory scrutiny?
Regulators have raised concerns about the assessment, prescribing, supply and promotion of weight management medicines, particularly where services operate online or commercial pressures may affect clinical decisions.
Key areas of focus for regulators include:
- Inappropriate or unsafe prescribing
- Remote prescribing without adequate clinical assessment
- Inadequate verification of patient information, including weight, height or BMI
- Pressure-driven commercial prescribing models
- Misleading advertising or marketing claims
- Supply chain integrity and sourcing of medicines
- Patient suitability, consent, monitoring and follow-up arrangements
- Cross-border or online prescribing services
- Lack of adequate patient assessment or follow-up
- Prescribing driven by commercial rather than clinical considerations
- Inadequate clinical governance structures
Providers need systems that support individual clinical judgment, reliable record-keeping and appropriate ongoing care. Commercial arraignments should not undermine a prescriber’s ability to decline or arrange further assessment.
If a regulator contacts you about a complaint, inspection or investigation, early legal advice can help you understand the issues, preserve relevant evidence and prepare an appropriate response.
Enforcement activity in this area has increased significantly in recent years. If you have been notified that an investigation is underway or that your regulator has received a complaint or referral, speak to the experienced solicitors at JMW at your earliest opportunity.
What are the rules about advertising weight loss injections?
Prescription-only medicines must not be advertised to the public. The prohibition covers direct advertising of named medicines and indirect promotion through wording, images or other references. Separate rules govern advertising to persons qualified to prescribe or supply medicines.
In consumer advertising for treatment services, references to GLP-1 medicines, weight loss injections, jabs or pens, and images of injection pens, can amount to prohibited promotion, even where no brand name is used.
Providers must carefully distinguish advertising a weight management consultation from promoting a prescription-only medicine. Describing an advertisement as promoting a service does not, by itself, make it compliant. Social media posts, influencer content, paid advertisements and promotional website material can all be found within the rules.
Marketing must comply with medicines advertising legislation and the CAP or BCAP Code, as applicable. Providers should also avoid misleading claims, irresponsible messages about body image and promotions that put pressure on people to make rushed treatment decisions.
JMW can review proposed campaigns, website wording and social media content and advise on responses to enquiries or complaints from the MHRA, ASA or other relevant regulators.
It is illegal to advertise prescription-only medicines in the UK, and there are strict penalties for those who break the rules in both broadcast and non-broadcast advertising. While this is not a comprehensive list of requirements, clinics and providers must generally ensure they do not:
- Advertise specific prescription medicines to the public
- Make misleading claims about weight loss outcomes
- Present medicines as cosmetic or lifestyle products
- Encourage inappropriate or unsupervised use
Marketing must be carefully structured to comply with medicines advertising rules and consumer protection law. The MHRA has increased action against businesses whose weight-loss advertising unlawfully promotes prescription-only medicines to the public. JMW's experienced media team can advise you on any specific rules that apply to a particular medicine and the general rules that you must follow to maintain ASA compliance.
What enforcement action can the MHRA take?
The MHRA can investigate suspected breaches of medicines legislation relating to the manufacture, importation, distribution, sale, supply and advertising of weight loss medicines. The action taken depends on the alleged breach, the available evidence and the risks involved, and other regulators are increasingly active in this area. Regulators can take enforcement action where weight-loss medicines are advertised, manufactured, supplied or sold in breach of medicines law.
The action it takes will depend on the nature and seriousness of the breach, but particular areas of concern for the MHRA have recently included:
- Illegal supply chains
- Falsified medicines and medicines manufactured, imported or supplied unlawfully
- Unlawful advertising of prescription-only or unlicensed medicines
- Breaches of licensing or authorisation requirements
- Unlicensed or improperly sourced medicines
- Unsafe prescribing arrangements
- Misleading marketing practices
- Patient safety risks
Investigations may involve inspections, information requests, searches and product seizures. Serious cases can involve the MHRA's Criminal Enforcement Unit, working with the police, Border Force and other agencies and may lead to prosecution. Financial investigations can also involve tracing, freezing and recovering assets through the relevant statutory and court processes.
For advertising breaches, the MHRA may seek amendments, withdrawal of material or corrective statements. It can also use statutory procedures, including notices to restrict publication and requirements to submit advertising for review. Informal resolution is common, but providers should not assume that a warning must precede formal action or prosecution.
JMW can advise on responding to MHRA correspondence, inspections, interviews under caution and criminal proceedings, as well as related professional disciplinary or healthcare regulatory issues.
Its activities include:
- investigating suspected offences and carrying out raids
- seizing illegal or unlicensed medicines
- disrupting websites, social-media accounts and online listings used to sell medicines illegally
- working with police, Border Force and other enforcement bodies
- tracing, freezing and recovering assets linked to medicines crime
- pursuing criminal prosecutions where there is sufficient evidence
Weight-loss medicines are already a significant area of MHRA enforcement and, even for lesser offences, serious penalties may apply. For example, for advertising breaches, the MHRA has the power to prosecute where appropriate. However, it will often first require a business to remove or amend non-compliant advertising. Under the Human Medicines Regulations 2012, it can also use formal statutory procedures, including serving notices requiring advertising to stop or requiring proposed advertising to be submitted for review before publication.
Frequently asked questions
- Are weight loss injections legal in the UK?
GLP-1 receptor agonists and other injectable weight loss medicines are legal in the UK but are classified as prescription-only medicines.
This means they must:
- Be prescribed by an appropriately qualified healthcare professional
- Be supplied through authorised legal supply chains
- Be used in accordance with clinical guidelines and regulatory requirements
- Be supported by appropriate patient assessment and monitoring
Failure to comply with these requirements can lead to serious regulatory consequences.
- Who can prescribe weight loss injections?
Weight loss medicines may only be prescribed by appropriately qualified prescribers acting within their competence and scope of practice. This includes:
- Doctors
- Independent nurse prescribers
- Independent pharmacist prescribers
However, prescribing must always be clinically justified and supported by appropriate assessment of the patient. Regulators expect prescribers to exercise independent clinical judgement, free from commercial pressure, and practitioners should keep documentation relating to patient visits and clinical decisions to support them should an investigation arise.
- Can I run a weight loss injection clinic?
Yes, but the clinic must comply with strict prescribing, governance and regulatory requirements.
The legal requirements depend on your proposed role, the professionals involved and how the service will operate. You should establish the requirements for healthcare registration, prescribing, medicines procurement and supply, clinical governance, indemnity and advertising before launching. Business ownership does not itself confer authority to prescribe or supply medicines.
- What are the risks of non-compliant prescribing?
Risks for prescribers include MHRA enforcement action, professional discipline, criminal investigation and reputational damage. There are also health risks for patients, and prescription errors that arise from non-compliance could leave clinics liable to medical negligence compensation claims by patients.
Talk to us
If you require legal advice on weight loss injection services or GLP-1 prescribing models, our specialist team can help. JMW advises clinics, prescribers and healthcare businesses across the UK on regulatory compliance and legal risk in this rapidly evolving area.
Call us today for advice on 0345 872 6666 or use our online enquiry form to request a call back at your convenience.
